2025 annual financial data
Kazia Therapeutics 2025 Revenue growth
Direct answer
Revenue growth was -98.18%.
Operating income was -14,217,000 AUD and net income was -20,702,000 AUD.
Operating cash flow was -13,278,000 AUD.
Get free Kazia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42,000 AUD
- Operating income
- -14,217,000 AUD
- Net income
- -20,702,000 AUD
- Operating cash flow
- -13,278,000 AUD